Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer

The treatment of anaplastic lymphoma kinase (ALK)-positive locally advanced non-small-cell lung cancer (NSCLC) is challenging because there is no randomized controlled trial has been reported. The value of neoadjuvant and adjuvant targeted therapy remains unclear. Herein, we show that systemic treat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Xie, Xiao-Hong, Zhan, Ze-Jiang, Qin, Yin-Yin, Jiang, Ju-Hong, Yin, Wei-Qiang, Zheng, Rong-Hui, Li, Shi-Yue, Zhou, Cheng-Zhi
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010235/
https://ncbi.nlm.nih.gov/pubmed/33816312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.655856
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky